[The influence of meproscillarin on human left ventricular function (author's transl)]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Left ventricular (LV) function is crucial for cardiac output.
• Assessing the inotropic effects of cardiac glycosides is important for heart failure management.

Purpose of the Study:

• To evaluate the effect of meproscillarin on left ventricular (LV) function.
• To determine if meproscillarin improves myocardial contractility.

Main Methods:

• Echocardiography was used to assess LV function in 11 cardiac patients.
• Patients received meproscillarin (0.25 mg four times daily) or placebo for 7 days.

Main Results:

• Meproscillarin significantly increased percent systolic shortening and mean velocity of circumferential fiber shortening (P < 0.001).
• No significant changes in LV function were observed during the placebo period.
• Heart rate and end-diastolic LV diameter remained unchanged.

Conclusions:

• Peroral meproscillarin demonstrated a significant positive inotropic effect on the left ventricle.
• Meproscillarin may be a valuable therapeutic agent for improving cardiac contractility.